Developing an ‘on and off’ Switch for Breast Cancer Treatment
T-cells play an important role in the body’s immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using these T-cells and genetically engineering them to kill cancer, but these cells, known as CAR-T cells, have been known to attack off-target sites while completing their job. In order to counteract this negative effect, University of Notre Dame researchers are working to create nanoparticles that act as an “on and off” switch to improve the safety and effectiveness of this cancer therapy.
Read more here.
August 17, 2018
More Like This
Related PostsLet your curiosity roam! If you enjoyed the insights here, we think you might enjoy discovering the following publications.
Driving Social Impact in public health and conservation
Driving Social Impact in public health and conservation
The Chip Makers
Low-cost, portable device could diagnose heart attacks in minutes
Liquid Sunshine: Scotch Whisky & Irish Whiskey
ND Explores STEM: Adult Beverages 101 (2022)
Savage Water: Tequila & Mezcal
Wine Marketing Trends & Innovations
China Town Hall 2022